![Mark Meltz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Meltz
Nessuna posizione attualmente
Storia della carriera di Mark Meltz
Precedenti posizioni note di Mark Meltz
Società | Posizione | Inizio | Fine |
---|---|---|---|
KINNATE BIOPHARMA INC. | Direttore operativo | 01/04/2020 | 03/04/2024 |
Direttore Finanziario/CFO | - | 07/06/2021 | |
Consigliere Generale | 01/04/2020 | 03/04/2024 | |
Segretario Aziendale | 01/05/2020 | 03/04/2024 | |
Treasurer | 01/05/2020 | 03/04/2024 | |
AUDENTES THERAPEUTICS, INC. | Consigliere Generale | 28/03/2019 | 01/02/2020 |
Emergent Travel Health, Inc.
![]() Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Consigliere Generale | 03/09/2014 | 01/03/2019 |
BIOGEN INC. | Consigliere Generale | 01/05/2007 | 01/03/2012 |
BMC Partners LLP
![]() BMC Partners LLP Miscellaneous Commercial ServicesCommercial Services BMC Partners LLP provides litigation, corporate, finance, restructuring, employment and benefits, and intellectual property services in all industries. It also offers consulting and advisory services in government, investment management, and mergers and acquisitions. The company was founded on July 1, 2002 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Novartis Vaccines & Diagnostics, Inc.
![]() Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Consigliere Generale | - | - |
Formazione di Mark Meltz
Boston College Law School | Graduate Degree |
Yale University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Posizioni
General Counsel | 5 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BIOGEN INC. | Health Technology |
Aziende private | 5 |
---|---|
Emergent Travel Health, Inc.
![]() Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
Novartis Vaccines & Diagnostics, Inc.
![]() Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
Astellas Gene Therapies, Inc.
![]() Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
Kinnate Biopharma, Inc.
![]() Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
BMC Partners LLP
![]() BMC Partners LLP Miscellaneous Commercial ServicesCommercial Services BMC Partners LLP provides litigation, corporate, finance, restructuring, employment and benefits, and intellectual property services in all industries. It also offers consulting and advisory services in government, investment management, and mergers and acquisitions. The company was founded on July 1, 2002 and is headquartered in Boston, MA. | Commercial Services |
- Borsa valori
- Insiders
- Mark Meltz
- Esperienza